Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Status: Recruiting
Location: See all (9) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• All people incarcerated at a study site during the intervention period

Locations
Other Locations
Canada
Fraser Valley Institution for Women
NOT_YET_RECRUITING
Abbotsford
Dorchester Medium
RECRUITING
Dorchester
Edmonton Institution for Women
NOT_YET_RECRUITING
Edmonton
Joliette Institution for Women
NOT_YET_RECRUITING
Joliette
Joyceville Institution
NOT_YET_RECRUITING
Kingston
Grand Valley Institution for Women
NOT_YET_RECRUITING
Kitchener
Mission Institution
NOT_YET_RECRUITING
Mission
Atlantic Institution
RECRUITING
Smiths Crossing
Nova Institution for Women
RECRUITING
Truro
Contact Information
Primary
Nadine Kronfli
nadine.kronfli@mcgill.ca
514-934-1934
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2029-09-30
Participants
Target number of participants: 548
Treatments
Experimental: NIATx group 1
Control (month 1-6) then NIATx (month 7-30) then Maintenance (month 31-42)
Experimental: NIATx group 2
Control (month 7-12) then NIATx (month 13-36) then Maintenance (month 37-48)
Experimental: NIATx group 3
Control (month 13-18) then NIATx (month 19-42) then Maintenance (month 43-54)
Related Therapeutic Areas
Sponsors
Collaborators: Yale University, Burnet Institute, Kirby Institute
Leads: McGill University Health Centre/Research Institute of the McGill University Health Centre

This content was sourced from clinicaltrials.gov